• Close Shade
  • Pin Shade
  • Expand Shade
Headline: Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant
Location: Berkeley, CA, USA
Post Date: Jul 16, 2020 8:43 AM
TAG ID: pznewsml315878
DocID: 202007167961007-en.newsml
Word Count: approx. 1782 words
 
Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 AdjuvantDynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant
 
Please login to download this Story